Procter and Gamble Health Limited has announced a final dividend of ₹45 per equity share (450% of face value) for the financial year ended March 31, 2026. According to an exchange filing dated May 26, 2026, the dividend will be paid on or before September 27, 2026, to shareholders whose names appear in the Register of Members as of the record date. The dividend has been recommended from the company's profits for the financial year 2025-26.
August 27, 2026, has been fixed as the record date to determine shareholders' eligibility for both the AGM attendance and dividend payment. As reported by ET Now, the company has informed that its 59th Annual General Meeting is scheduled for September 3, 2026, at 2:30 PM. The final dividend payment is contingent upon approval by shareholders at the ensuing AGM. In line with Ministry of Corporate Affairs and SEBI guidelines, the documents were sent electronically on August 12, 2026, to members whose email addresses are registered with the company, while physical letters containing links to the Annual Report and AGM notice were dispatched to shareholders without registered email addresses.
Procter and Gamble Health shares are currently trading at ₹5,833.00 as of August 25, 2026, showing a 0.47% decline from the previous close of ₹5,873.50. According to Upstox data, the stock opened at ₹5,860.00 and moved in the trading range of ₹5,806.50 to ₹5,873.50 during the session, with an average price of ₹5,840.00 for the day. The stock has demonstrated strong 13.81% growth over the last six months, though it remains 10.76% down on a year-on-year basis. The stock reached its 52-week high level on July 15, 2026, at ₹6,975 per share, while the 52-week low level came in at ₹4,707 per share on April 6, 2026.
Procter and Gamble Health is a constituent of BSE 1000 index and enjoys a market capitalisation of ₹9,677.44 crore. According to ET Now, the company is a pharmaceuticals company and this dividend announcement represents a significant payout to shareholders from their financial year 2025-26 performance. The company's 59th Annual General Meeting is scheduled for September 3, 2026, at 2:30 PM, with the intimation addressed to both BSE Limited and NSE Limited. The filing was signed by Zeal Rupani, Company Secretary of Procter & Gamble Health Limited.
